Annual D&A
$492.00 K
+$282.00 K+134.29%
December 31, 2023
Summary
- As of February 8, 2025, VIRX annual depreciation & amortization is $492.00 thousand, with the most recent change of +$282.00 thousand (+134.29%) on December 31, 2023.
- During the last 3 years, VIRX annual D&A has risen by +$460.00 thousand (+1437.50%).
- VIRX annual D&A is now at all-time high.
Performance
VIRX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$110.00 K
+$14.00 K+14.58%
September 30, 2024
Summary
- As of February 8, 2025, VIRX quarterly depreciation & amortization is $110.00 thousand, with the most recent change of +$14.00 thousand (+14.58%) on September 30, 2024.
- Over the past year, VIRX quarterly D&A has dropped by -$13.00 thousand (-10.57%).
- VIRX quarterly D&A is now -14.06% below its all-time high of $128.00 thousand, reached on September 30, 2023.
Performance
VIRX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$439.00 K
-$18.00 K-3.94%
September 30, 2024
Summary
- As of February 8, 2025, VIRX TTM depreciation & amortization is $439.00 thousand, with the most recent change of -$18.00 thousand (-3.94%) on September 30, 2024.
- Over the past year, VIRX TTM D&A has dropped by -$53.00 thousand (-10.77%).
- VIRX TTM D&A is now -10.77% below its all-time high of $492.00 thousand, reached on December 31, 2023.
Performance
VIRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
VIRX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +134.3% | -10.6% | -10.8% |
| 3 y3 years | +1437.5% | -10.6% | -10.8% |
| 5 y5 years | +1437.5% | -10.6% | -10.8% |
VIRX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +176.4% | -14.1% | +144.4% | -10.8% | +146.6% |
| 5 y | 5-year | at high | +1437.5% | -14.1% | +5400.0% | -10.8% | >+9999.0% |
| alltime | all time | at high | +1437.5% | -14.1% | +5400.0% | -10.8% | >+9999.0% |
Viracta Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $110.00 K(+14.6%) | $439.00 K(-3.9%) |
| Jun 2024 | - | $96.00 K(-12.7%) | $457.00 K(-4.8%) |
| Mar 2024 | - | $110.00 K(-10.6%) | $480.00 K(-2.4%) |
| Dec 2023 | $492.00 K(+134.3%) | $123.00 K(-3.9%) | $492.00 K(+15.5%) |
| Sep 2023 | - | $128.00 K(+7.6%) | $426.00 K(+24.2%) |
| Jun 2023 | - | $119.00 K(-2.5%) | $343.00 K(+23.4%) |
| Mar 2023 | - | $122.00 K(+114.0%) | $278.00 K(+32.4%) |
| Dec 2022 | $210.00 K | $57.00 K(+26.7%) | $210.00 K(-0.9%) |
| Sep 2022 | - | $45.00 K(-16.7%) | $212.00 K(-3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $54.00 K(0.0%) | $219.00 K(+1.4%) |
| Mar 2022 | - | $54.00 K(-8.5%) | $216.00 K(+21.3%) |
| Dec 2021 | $178.00 K(+456.3%) | $59.00 K(+13.5%) | $178.00 K(+30.9%) |
| Sep 2021 | - | $52.00 K(+2.0%) | $136.00 K(+43.2%) |
| Jun 2021 | - | $51.00 K(+218.8%) | $95.00 K(+106.5%) |
| Mar 2021 | - | $16.00 K(-5.9%) | $46.00 K(+43.8%) |
| Dec 2020 | $32.00 K | $17.00 K(+54.5%) | $32.00 K(+113.3%) |
| Sep 2020 | - | $11.00 K(+450.0%) | $15.00 K(+275.0%) |
| Jun 2020 | - | $2000.00(0.0%) | $4000.00(+100.0%) |
| Mar 2020 | - | $2000.00 | $2000.00 |
FAQ
- What is Viracta Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Viracta Therapeutics?
- What is Viracta Therapeutics annual D&A year-on-year change?
- What is Viracta Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Viracta Therapeutics?
- What is Viracta Therapeutics quarterly D&A year-on-year change?
- What is Viracta Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Viracta Therapeutics?
- What is Viracta Therapeutics TTM D&A year-on-year change?
What is Viracta Therapeutics annual depreciation & amortization?
The current annual D&A of VIRX is $492.00 K
What is the all time high annual D&A for Viracta Therapeutics?
Viracta Therapeutics all-time high annual depreciation & amortization is $492.00 K
What is Viracta Therapeutics annual D&A year-on-year change?
Over the past year, VIRX annual depreciation & amortization has changed by +$282.00 K (+134.29%)
What is Viracta Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of VIRX is $110.00 K
What is the all time high quarterly D&A for Viracta Therapeutics?
Viracta Therapeutics all-time high quarterly depreciation & amortization is $128.00 K
What is Viracta Therapeutics quarterly D&A year-on-year change?
Over the past year, VIRX quarterly depreciation & amortization has changed by -$13.00 K (-10.57%)
What is Viracta Therapeutics TTM depreciation & amortization?
The current TTM D&A of VIRX is $439.00 K
What is the all time high TTM D&A for Viracta Therapeutics?
Viracta Therapeutics all-time high TTM depreciation & amortization is $492.00 K
What is Viracta Therapeutics TTM D&A year-on-year change?
Over the past year, VIRX TTM depreciation & amortization has changed by -$53.00 K (-10.77%)